Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.

Shen E, Liu C, Wei L, Hu J, Weng J, Yin Q, Wang Y.

Tumour Biol. 2014 Mar;35(3):2529-35. doi: 10.1007/s13277-013-1334-6. Epub 2013 Nov 20.

PMID:
24254302
2.

Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis.

Dai ZJ, Shao YP, Kang HF, Tang W, Xu D, Zhao Y, Liu D, Wang M, Yang PT, Wang XJ.

World J Gastroenterol. 2015 Apr 28;21(16):5081-9. doi: 10.3748/wjg.v21.i16.5081. Review.

3.

The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.

Zhao Z, Liu C, Zeng Y, Gu L, Ying M, Wang N, Hao B, Yao H, Su C, Wang Y, Ma Y.

Tumour Biol. 2014 May;35(5):4727-34. doi: 10.1007/s13277-014-1618-5. Epub 2014 Jan 14.

PMID:
24414702
4.

The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.

Zhou X, Wei L, Jiao G, Gao W, Ying M, Wang N, Wang Y, Liu C.

Mol Genet Genomics. 2015 Feb;290(1):281-8. doi: 10.1007/s00438-014-0916-3. Epub 2014 Sep 19.

PMID:
25234162
5.

Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.

Li X, Zhang G, Huai YJ, Cao ZQ.

Tumour Biol. 2014 Oct;35(10):10111-9. doi: 10.1007/s13277-014-2115-6. Epub 2014 Jul 15. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
25023401
6.

APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis.

Liu C, Yin Q, Li L, Zhuang YZ, Zu X, Wang Y.

Mol Biol Rep. 2013 Jan;40(1):171-6. doi: 10.1007/s11033-012-2046-5. Epub 2012 Nov 10.

PMID:
23143180
7.

APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Ji YN, Zhan P, Wang J, Qiu LX, Yu LK.

Mol Biol Rep. 2011 Oct;38(7):4537-43. doi: 10.1007/s11033-010-0584-2. Epub 2010 Dec 4.

PMID:
21132382
8.

APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Zhang SH, Wang LA, Li Z, Peng Y, Cun YP, Dai N, Cheng Y, Xiao H, Xiong YL, Wang D.

World J Gastroenterol. 2014 Jul 14;20(26):8700-8. doi: 10.3748/wjg.v20.i26.8700.

9.

Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.

Wei W, He XF, Qin JB, Su J, Li SX, Liu Y, Zhang Y, Wang W.

Mol Biol Rep. 2012 Dec;39(12):11249-62. doi: 10.1007/s11033-012-2035-8. Epub 2012 Oct 12.

PMID:
23065211
10.

The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: a meta-analysis based on 37 case-control studies.

Zhou B, Shan H, Su Y, Xia K, Shao X, Mao W, Shao Q.

BMC Cancer. 2011 Dec 18;11:521. doi: 10.1186/1471-2407-11-521. Review.

11.

Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.

Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J, Qin X, Li S.

Diagn Pathol. 2014 Jun 3;9:108. doi: 10.1186/1746-1596-9-108. Review.

12.

APE1 Asp148Glu polymorphism and lung cancer susceptibility.

Cai L, Fu Y, Zhang Y.

Tumour Biol. 2014 Jun;35(6):5237-44. doi: 10.1007/s13277-014-1681-y. Epub 2014 Feb 13.

PMID:
24523018
13.

The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.

Gu D, Wang M, Wang M, Zhang Z, Chen J.

Mutagenesis. 2009 Nov;24(6):507-12. doi: 10.1093/mutage/gep036. Epub 2009 Sep 17.

PMID:
19762350
14.

Letter regarding Shen et al. entitled "The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis".

Liu F, Wei YG, Wang WT, Li B.

Tumour Biol. 2014 Dec;35(12):12775-6. doi: 10.1007/s13277-014-2804-1. Epub 2014 Nov 11. No abstract available.

PMID:
25384510
15.

Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.

Kasahara M, Osawa K, Yoshida K, Miyaishi A, Osawa Y, Inoue N, Tsutou A, Tabuchi Y, Tanaka K, Yamamoto M, Shimada E, Takahashi J.

J Exp Clin Cancer Res. 2008 Sep 30;27:49. doi: 10.1186/1756-9966-27-49.

16.

Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Meng Q, Zhang J, Lian B, Song C.

Tumour Biol. 2014 Mar;35(3):2367-72. doi: 10.1007/s13277-013-1312-z. Epub 2013 Nov 1.

PMID:
24178910
17.

Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.

Li Y, Li S, Wu Z, Hu F, Zhu L, Zhao X, Cui B, Dong X, Tian S, Wang F, Zhao Y.

Med Oncol. 2013 Jun;30(2):505. doi: 10.1007/s12032-013-0505-z. Epub 2013 Feb 22.

PMID:
23430444
18.

The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.

Wang HG, Wu QY, Zhou H, Peng XS, Shi MJ, Li JM, Zhou YF.

Asian Pac J Cancer Prev. 2014;15(13):5277-81.

19.

A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.

Kang H, Dai Z, Ma X, Ma L, Jin Y, Liu X, Wang X.

Gene. 2013 Nov 15;531(1):97-100. doi: 10.1016/j.gene.2013.08.052. Epub 2013 Aug 28.

PMID:
23994194
20.

The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.

Chen W, Wang Q, Liu M, Ding XB.

Tumour Biol. 2014 Apr;35(4):3597-603. doi: 10.1007/s13277-013-1474-8. Epub 2013 Dec 6.

PMID:
24310503

Supplemental Content

Support Center